Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation

Goetghebuer, TessaTessaGoetghebuerLe Chenadec, JeromeJeromeLe ChenadecHaelterman, EdwigeEdwigeHaeltermanGalli, LuisaLuisaGalliDollfus, CatherineCatherineDollfusThorne, ClaireClaireThorneJudd, AliAliJuddKeiser, OliviaOliviaKeiser0000-0001-8191-2789Ramos, Jose TomasJose TomasRamosLevy, JackJackLevyWarszawski, JosianeJosianeWarszawskiEuropean Infant Collaboration, GroupGroupEuropean Infant Collaboration2024-10-112024-10-112012https://boris-portal.unibe.ch/handle/20.500.12422/77824The clinical benefit of antiretroviral therapy in infants is established. In this cohort collaboration, we compare immunological and virological response to treatment started before or after 3 months of age. Early initiation provides a better short-term response, although evolution after 12 months of age is similar in both groups.en600 - Technology::610 - Medicine & healthShort- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiationarticle10.7892/boris.73692219878800030079090002410.1093/cid/cir950